Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michihiko Hasegawa is active.

Publication


Featured researches published by Michihiko Hasegawa.


World Journal of Surgery | 2000

Prevention of renal cell carcinoma by active vitamin D3.

Tomoaki Fujioka; Yasushi Suzuki; Tomoshi Okamoto; Nozomi Mastushita; Michihiko Hasegawa; So Omori

A bstractWe studied the serum levels of 1,25-dihydroxyvitamin D [1,25(OH)2D (Vit D)] in patients with renal cell carcinoma (RCC) and the influence of 1,25(OH)2D3 (Vit D3) on gap junctional intercellular communication (GJIC) during carcinogenesis. The serum Vit D levels were measured by a competitive protein-binding assay using the chromatographic method. Using the [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT) assay, noncytotoxic concentrations of Vit D3 and the tumor promoters N-nitrosodimethylamine (NDMA) and N-ethyl-N-hydroxyethylnitrosamine (EHEN) were tested against cultured human renal proximal tubular cells (HRPTCs). GJIC function was assayed by the scrape-loading dye transfer technique. Cx43 mRNA expression was also examined by the reverse transcriptase-polymerase chain reaction (RT-PCR). Serum Vit D levels in patients with RCC were lower than those in controls (p < 0.001). Patients with T3 to T4 (rapid-growth) tumors had lower levels of Vit D than did patients with T1 to T2 (slow-growth) tumors (p < 0.001). Vit D3 enhanced the GJIC function of HRPTCs (p < 0.05), whereas NDMA and EHEN suppressed it (p < 0.05). When the cells were treated with tumor promoters and Vit D3 simultaneously, the GJIC functions remained at pretreatment levels. We also demonstrated Cx43 mRNA expression in RPTECs treated with EHEN and VitD3 simultaneously. These data suggest that a decrease in the serum Vit D level is one of the risk factors for development and progression of RCC, and Vit D3 may prevent RCC by preserving GJIC during carcinogenesis.


International Journal of Urology | 2007

Prevalence of renal cell carcinoma: A nation-wide survey in Japan, 2002

Ken Marumo; Hiro-omi Kanayama; Noriomi Miyao; Hayakazu Nakazawa; Seiichiro Ozono; Shigeo Horie; Satoshi Nagamori; Tatsuo Igarashi; Michihiko Hasegawa; Go Kimura; Masahiro Nakao; Takahisa Nakamoto; Seiji Naito

Objective:  To investigate the incidence of renal cell carcinoma, classified by sex, age group and region in Japan, following a 5‐year interval after a previous survey performed in 1997.


International Journal of Urology | 2008

Primary mucosa‐associated lymphoid tissue‐type lymphoma arising in the kidney

Yoichiro Kato; Michihiko Hasegawa; Susumu Numasato; Nobuhiro Monma; Tomoaki Fujioka

Abstract:  We report a case of primary low‐grade lymphoma of mucosa‐associated lymphoid tissue (MALT) arising from the kidney in a 30‐year‐old man with an abdominal mass in the right flank detected by ultrasonography. Radical nephrectomy was performed under a preliminary diagnosis of renal cell carcinoma. The final histological diagnosis was MALT‐type lymphoma. To the best of our knowledge, only five reports of primary MALT‐type lymphoma in the kidney have been published in the literature so far. All cases were surgically treated and only one case went on to chemotherapy postoperatively.


International Journal of Urology | 2007

Surgical outcomes of partial nephrectomy for renal cell carcinoma : A joint study by the Japanese Society of Renal Cancer

Yutaka Senga; Seiichiro Ozono; Hayakazu Nakazawa; Satoshi Nagamori; Ken Marumo; Shigeo Horie; Tetsuro Onishi; Noriomi Miyao; Masahiro Nakao; Tatsuo Igarashi; Tomoyasu Tsushima; Michihiko Hasegawa; Masaru Murai

Objective:  A joint study was undertaken by the Japanese Society of Renal Cancer to investigate the present status of partial nephrectomy in Japan and to speculate about what may be the indications for partial nephrectomy in patients with renal cell carcinoma.


Hinyokika kiyo. Acta urologica Japonica | 1994

Clinical study of renal cell carcinoma invading adjacent organs

Koichi Ishikura; Yoshida N; Michihiko Hasegawa; Nomura K; Tomoshi Okamoto; Susumu Tanji; Tomoaki Fujioka; Tsutomu Ohhori; Takashi Kubo


Annals of Cancer Research and Therapy | 1994

Serum immunosuppressive acidic protein in renal cell carcinoma

Tomoaki Fujioka; Koichi Ishikura; Michihiko Hasegawa; Naoto Yoshiba; Yasushi Matusita; Masatugu Sato; Yasuki Goto; Nomura K; Susumu Tanji; Tomoshi Okamoto; Takashi Kubo


Hinyokika kiyo. Acta urologica Japonica | 1991

EPIDERMAL GROWTH FACTOR IN THE URINE OF PATIENTS WITH RENAL CELL CARCINOMA AND BLADDER TUMOR

Koichi Ishikura; Michihiko Hasegawa; Nomura K; Tomoshi Okamoto; Susumu Tanji; Abe T; Tomoaki Fujioka; Tsutomu Ohhori; Takashi Kubo


Hinyokika kiyo. Acta urologica Japonica | 1993

A case of adrenal myelolipoma incidentally discovered on abdominal ultrasonography

Sato F; Michihiko Hasegawa; Suzuki K; Kurosawa T; Tomoaki Fujioka; Takashi Kubo


The Journal of Urology | 1999

EFFECTS OF ACTIVE VITAMINE D ON GAP JUNCTIONAL INTRACELLULAR COMMUNICATION IN RENAL TUBULAR EPITHELIAL CELLS DURING CARCINOGENESIS

Tomoaki Fujioka; Yasushi Suzuki; Tohru Suzuki; Hideo Tokunaga; Nozomi Matsushita; Michihiko Hasegawa


Hinyokika kiyo. Acta urologica Japonica | 1994

A case of renal liposarcoma

Koike H; Ra S; Michihiko Hasegawa; Susumu Tanji; Tomoaki Fujioka; Takashi Kubo

Collaboration


Dive into the Michihiko Hasegawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takashi Kubo

Iwate Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Susumu Tanji

Iwate Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Noriomi Miyao

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge